Novo Nordisk partners with Variant Bio, paying up to $50M upfront for metabolic disease targets. Some funds will support Indigenous communities that provided data.
Advocates celebrate 2023 legislation capping insulin prices for people on the state employee health insurance plan in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback